Attached files

file filename
EX-10.4 - CONSULTING AGREEMENT - Bullfrog Gold Corp.g1100904_ex10-4.htm
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 17, 2012
(Exact Name of Registrant as Specified in Charter)
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
897 Quail Run Drive, Grand Junction, Colorado
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (970) 628-1670

(Former name or former address, if changed since last report)
Copies to:
Harvey J. Kesner, Esq.
61 Broadway, 32nd Floor
New York, New York 10006
Telephone: (212) 930-9700

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 Item 1.01 Entry into a Material Definitive Agreement.


On December 17, 2012, Bullfrog Gold Corp. (the “Company”) entered into a consulting agreement (the “Consulting Agreement”) with Antibes International Corp. (“Antibes”) to provide management consulting, business advisory, shareholder information and public relations services to the Company. In connection with the Consulting Agreement, the Company paid Antibes $500,000 from the proceeds of a private placement described in Item 3.02 below. In the event that the Company shall sell additional Units (as defined below) in subsequent closings of a private placement on the same terms as the private placement described below, then the Company is obligated to pay Antibes up to an additional $500,000 (for a total of $1.0 million in the aggregate). The Consulting Agreement may be terminated by the Company for any reason, with or without cause, upon three (3) days written notice to Antibes. In addition, the Consulting Agreement may be terminated by either party upon giving written notice to the other party if the other party is in default hereunder and such default is not cured within fifteen (15) days of receipt of written notice of such default.

The foregoing description does not purport to be complete and is qualified in its entirety by reference to the complete text of the Consulting Agreement filed as Exhibit 10.4 hereto which is incorporated by reference.

Item 3.02

Unregistered Sales of Equity Securities.


On December 17, 2012, the Company sold an aggregate of 2,000,000 units (the “Units”) with gross proceeds to the Company of $500,000 to certain accredited investors (the “Investors”) pursuant to a subscription agreement (the “Subscription Agreement”). The Company utilized the proceeds of the private placement to pay Antibes for its services under the Consulting Agreement as described in Item 1.01 above.


Each Unit was sold for a purchase price of $0.25 per Unit and consisted of: (i) one share of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) and (ii) a four-year warrant (the “Warrants”) to purchase one hundred (100%) percent of the number of shares of Common Stock purchased at an exercise price of $0.35 per share, subject to adjustment upon the occurrence of certain events such as stock splits and dividends. In connection with the private placement, the Company issued an aggregate of 2,000,000 shares of its Common Stock.


The Warrants may be exercised on a cashless basis if at any time there is no effective registration statement within 90 days after the closing date of the private placement covering the resale of the shares of Common Stock underlying the Warrants. The Warrants contains limitations on the holder’s ability to exercise the Warrant in the event such exercise causes the holder to beneficially own in excess of 4.99% of the Company’s issued and outstanding Common Stock, subject to a discretionary increase in such limitation by the holder to 9.99% upon 61 days’ notice.


The Company has entered into registration rights agreements with the Investors, pursuant to which the Company has agreed to file a “resale” registration statement with the SEC covering all shares of the Common Stock sold in the Offering and underlying any Warrants, as well as Common Stock underlying the warrants issued to the placement agent(s) on or prior to December 19, 2012 (the “Filing Date”).  The Company has agreed to maintain the effectiveness of the registration statement from the effective date until all securities have been sold or are otherwise able to be sold pursuant to Rule 144. The Company has agreed to use its reasonable best efforts to have the registration statement declared effective within 90 days (the “Effectiveness Deadline”).


The Company is obligated to pay to Investors a fee of 1% per month of the Investors’ investment, payable in cash, for every thirty (30) day period up to a maximum of 6%, (i) following the Filing Date that the registration statement has not been filed and (ii) following the Effectiveness Deadline that the registration statement has not been declared effective; provided, however, that the Company shall not be obligated to pay any such liquidated damages if the Company is unable to fulfill its registration obligations as a result of rules, regulations, positions or releases issued or actions taken by the SEC pursuant to its authority with respect to “Rule 415”, provided the Company registers at such time the maximum number of shares of common stock permissible upon consultation with the staff of the SEC.



The foregoing is not a complete summary of the terms of the offering described in this Item 3.02 and reference is made to the complete text of the Subscription Agreement, the Warrant and the Registration Rights Agreement respectively attached as Exhibits 10.1-10.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 20, 2012, and hereby incorporated by reference.


The Units were issued to “accredited investors,” as such term is defined in the Securities Act of 1933, as amended (the “Securities Act”) and were offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities.




Item 9.01 Financial Statements and Exhibits


(d)           Exhibits.


Exhibit No . Description










Form of Subscription Agreement(1)


Form of Warrant(1)


Form of Registration Rights Agreement(1)


Consulting Agreement*


 * Filed herewith

(1) Incorporated by reference to the Current Report on Form 8-K, filed with the SEC on November 20, 2012 







Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date:  December 17, 2012


  By:  /s/ David Beling  
    Name:  David Beling  
    Title:    President, Chief Executive Officer and Chief Financial Officer